Navigation Links
2 Independent Studies Released on the Effectiveness of Prostate Cancer Treatment
Date:9/1/2009

WESTMONT, Ill., Sept. 1 /PRNewswire/ -- For years, the debate has been ongoing regarding the best treatment method for prostate cancer patients. Now, two independent studies have reached similar conclusions. Already considered a good option for prostate cancer patients, brachytherapy (radiation seed implants) now has the backing of research from the Prostate Cancer Foundation of Chicago and The Taussig Cancer Center at Cleveland Clinic, proving a superior disease-free survival rate for patients with early stage prostate cancer.

In an 11-year study, the Prostate Cancer Foundation of Chicago, a non-profit organization that funds patient support programs, clinical research and public education, analyzed 9,137 patients between 1997 and 2008 who were treated for prostate cancer with brachytherapy at Chicago Prostate Center. 67.5% of the patients were regarded as low risk, 29.36% as intermediate, and 1.01% as high.

Of those patients, overall cure rates were 96%, 84%, and 75% for low, intermediate, and high risk patients, respectively. When combined with external beam radiation therapy in intermediate and high risk patients, the brachytherapy results far exceed those of surgery.

The Taussig Cancer Center at Cleveland Clinic has released their similar 2008 outcomes, demonstrating brachytherapy to be superior to surgery in all cases. For low risk patients, the study found a 95% survival rate after five years, 89% for intermediate risk, and 71% for high risk patients. This research concluded that, for low risk patients, brachytherapy was equally successful as external beam radiation, but more successful than a radical prostatectomy.

In addition to its effectiveness, brachytherapy is a minimally invasive treatment. Patients with prostate cancer in the T1 or T2 stages (meaning the cancer hasn't spread beyond the prostate) choose brachytherapy for a number of reasons:

  • No incisions, minimal pain and blood loss
  • Urinary incontinence rates less than 1% - compared to 10% with surgery
  • 6-25% chance of sexual dysfunction following procedure - compared to 50% with surgery
  • Lower rates of bowel irritation compared to external beam radiation
  • Convenience - one-time, outpatient procedure, patients can return to normal activity within a day
  • Lower cost compared to external beam radiation and surgery

For more information on the Prostate Cancer Foundation of Chicago research, visit www.chicagoprostatefoundation.org. For more information on the Taussig Cancer Center at Cleveland Clinic, visit http://my.clevelandclinic.org/services/radiation_oncology/outcomes.aspx.


'/>"/>
SOURCE Prostate Cancer Foundation of Chicago
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
2. PCMA Statement on the Independent Drugstore Lobby Agenda
3. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
4. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
5. Nationwide independent Taser study results suggest devices are safe
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. Schwab Institutional Introduces Healthcare and Benefits Assistance for Independent Advisor Firms
8. GHI to Provide Independent Personal Health Advocate for Medicare Members
9. PCMA Statement on Independent Pharmacy Antitrust Legislation
10. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
11. Medical Services Receives Independent Test Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology: